Amitriptyline plus fluphenazine to prevent chemotherapy-induced emesis in cancer patients: a double-blind randomized cross-over study
- 1 September 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (9), 1147-1150
- https://doi.org/10.1016/0277-5379(84)90123-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Delta-9-Tetrahydrocannabinol in Cancer Chemotherapy: Research Problems and IssuesAnnals of Internal Medicine, 1983
- Antiemetics and cytotoxic drugs.BMJ, 1983
- Cannabis and cancer chemotherapy. A comparison of oral delta-9-thc and prochlorperazineCancer, 1982
- Metoclopramide as an Antiemetic in ChemotherapyNew England Journal of Medicine, 1982
- Intravenous MetoclopramidePublished by American Medical Association (AMA) ,1982
- ANTIEMETICS: NEUROTRANSMITTER RECEPTOR BINDING PREDICTS THERAPEUTIC ACTIONSThe Lancet, 1982
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Phylogenic and Neurologic Aspects of the Vomiting ProcessThe Journal of Clinical Pharmacology, 1981
- Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potencyAmerican Journal of Psychiatry, 1980
- Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics.BMJ, 1979